117 related articles for article (PubMed ID: 7521274)
1. Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells.
Akita K; Dusting GJ; Hickey H
Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):231-3. PubMed ID: 7521274
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
Dusting GJ; Akita K; Hickey H; Smith M; Gurevich V
Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells.
Marumo T; Nakaki T; Hishikawa K; Suzuki H; Kato R; Saruta T
Hypertension; 1995 Apr; 25(4 Pt 2):764-8. PubMed ID: 7536714
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages.
Hattori Y; Nakanishi N
Cell Immunol; 1995 Oct; 165(1):7-11. PubMed ID: 7545550
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis.
Ciornei CD; Egesten A; Engström M; Törnebrandt K; Bodelsson M
Acta Anaesthesiol Scand; 2002 Oct; 46(9):1111-8. PubMed ID: 12366506
[TBL] [Abstract][Full Text] [Related]
6. Diethyldithiocarbamate ameliorates the effect of lipopolysaccharide on both increased nitrite production by vascular smooth muscle cells and decreased contractile response of aortic rings.
Loegering DJ; Richard CA; Davison CB; Wirth GA
Life Sci; 1995; 57(2):169-76. PubMed ID: 7541501
[TBL] [Abstract][Full Text] [Related]
7. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.
Wileman SM; Mann GE; Baydoun AR
Br J Pharmacol; 1995 Dec; 116(8):3243-50. PubMed ID: 8719803
[TBL] [Abstract][Full Text] [Related]
8. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta.
Shimizu S; Ishii M; Kawakami Y; Kiuchi Y; Momose K; Yamamoto T
Life Sci; 1999; 65(26):2769-79. PubMed ID: 10622266
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.
Strestíková P; Otová B; Filipec M; Farghali H
Physiol Res; 2000; 49(6):725-8. PubMed ID: 11252540
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic concentrations of tacrolimus do not interfere with endothelial nitric oxide synthesis in rat thoracic aortas and coronary arteries.
Can C; Erol A; Cinar M; Olukman M; Ulker S; Evinç A
J Cardiovasc Pharmacol; 2007 Oct; 50(4):399-405. PubMed ID: 18049307
[TBL] [Abstract][Full Text] [Related]
11. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro.
Ciornei CD; Egesten A; Bodelsson M
Acta Anaesthesiol Scand; 2003 Feb; 47(2):213-20. PubMed ID: 12631052
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin augmentation of interleukin-1 beta-induced production of nitric oxide in smooth-muscle cells.
Suzuki S; Takenaka K; Kassell NF; Lee KS
J Neurosurg; 1994 Dec; 81(6):895-901. PubMed ID: 7965120
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes.
Kaibori M; Sakitani K; Oda M; Kamiyama Y; Masu Y; Nishizawa M; Ito S; Okumura T
J Hepatol; 1999 Jun; 30(6):1138-45. PubMed ID: 10406194
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
Zingarelli B; Haskó G; Salzman AL; Szabó C
Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
Ikeda U; Shimada K
Eur J Pharmacol; 1994 Nov; 269(3):319-23. PubMed ID: 7534708
[TBL] [Abstract][Full Text] [Related]
16. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells.
Ikeda U; Kurosaki K; Ohya K; Shimada K
Cardiovasc Res; 1997 Jul; 35(1):168-74. PubMed ID: 9302361
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1.
Ikeda U; Kanbe T; Shimada K
Hypertension; 1996 Jun; 27(6):1240-4. PubMed ID: 8641730
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells.
Ikeda U; Ikeda M; Minota S; Shimada K
Circulation; 1999 Mar; 99(9):1230-5. PubMed ID: 10069792
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity.
Conde M; Andrade J; Bedoya FJ; Santa Maria C; Sobrino F
Immunology; 1995 Mar; 84(3):476-81. PubMed ID: 7538492
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
Zhou J; Struthers AD; Lyles GA
Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
